Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -28.58-29.41127.17-8.50468.50

What is the latest EBIT Growth ratio of BAFNA PHARMACEUTICALS ?

The latest EBIT Growth ratio of BAFNA PHARMACEUTICALS is -28.58 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025-28.58
Mar2024-29.41
Mar2023127.17
Mar2022-8.50
Mar2021468.50

How is EBIT Growth of BAFNA PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -28.58
Negative
Mar2024 -29.41
Negative
Mar2023 127.17
Positive
Mar2022 -8.5
Negative
Mar2021 468.5 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹303.4 Cr 6.8% -17.2% 49.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

6.8%

-17.2%

49.6%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses